Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-17-041060
Filing Date
2017-06-20
Accepted
2017-06-20 16:06:34
Documents
1
Period of Report
2017-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 7199
  Complete submission text file 0001209191-17-041060.txt   8500
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 290 COMMONWEALTH AVENUE #17 BOSTON MA 02115
Business Address
BARKER RICHARD W (Reporting) CIK: 0001255954 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34912 | Film No.: 17920924